22 July, 2021

Pharmaceutical company Sanofi have advised that their MS disease modifying therapy Aubagio will be delisted from the Australian market from October 2021.

stem cells
19 July, 2021

Australian researchers and disease-based charities are working together to promote and simplify access to evidence-based stem cell therapies in Australia.

ms risk and relapse DNA
14 July, 2021

Genes affect the risk of developing MS, but what about MS relapses? Two new studies uncover clues to MS biology hidden in our genetic code.

MS Subtypes MRI
14 July, 2021

MS is traditionally split into subtypes: relapsing-remitting, secondary-progressive, primary-progressive and progressive-relapsing. Researchers are now exploring three different subtypes based on machine learning.

15 June, 2021

MS Research Australia is currently funding 62 research projects covering a range of MS research priorities, including causes and prevention, better treatments and reversal of disability through repair or regeneration of cells.

challenge-awards progressive ms research
01 June, 2021

The International Progressive MS Alliance has just announced the recipients of this year’s Research Challenge awards, that will channel €1,425,000 (AUD $ 2,249,000) into identifying new therapeutic targets in progressive MS.

26 October, 2020

Mayzent (siponimod) the first MS medication approved for secondary progessive MS in Australia, has been listed on the Pharmaceutical Benefits Scheme (PBS).

lifestyle guide for MS
27 August, 2020

Australian experts have teamed up with MS Research Australia to build an evidence-based lifestyle guide to help people living with MS.

messenger molecules, ms risk genes and a potential new diagnosis tool
14 July, 2020

Two MS Research Australia funded research groups are investigating the role of messenger molecules and uncovering how genes increase the risk of ms.

super charging mitochondria - potential pathway to treat progressive ms
14 July, 2020

New research from the International Progressive MS Alliance discovers a way nerve fibres protect themselves from damage.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search